Information gathering, such as any current medical issues, personal and family medical history, and school records.Medical exam, to help rule out other possible causes of symptoms.Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.Īlways consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.There's no specific test for ADHD, but making a diagnosis will likely include: Has a currently accepted medical use in treatment in the United States. Has a low potential for abuse relative to those in schedule 4. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Has a low potential for abuse relative to those in schedule 3. Abuse may lead to moderate or low physical dependence or high psychological dependence. Has a potential for abuse less than those in schedules 1 and 2. Abuse may lead to severe psychological or physical dependence. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. There is a lack of accepted safety for use under medical supervision. Has no currently accepted medical use in treatment in the United States. Is not subject to the Controlled Substances Act. The schedule may depend on the exact dosage form or strength of the medication. Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits. There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. This medication may not be approved by the FDA for the treatment of this condition.Īn Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.Įxpanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.Īdequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).Īnimal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.Īnimal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. The following list of medications are in some way related to or used in the treatment of this condition.įor ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).Īctivity is based on recent site visitor activity relative to other medications in the list. Examples include venlafaxine and fluoxetine. These are not specifically approved for ADHD but commonly prescribed. Examples include atomoxetine ( Strattera), and guanfacine ( Intuniv). They may be prescribed if stimulants are ineffective or have side effects but take longer to work (>3 weeks). Non-stimulants work by increasing norepinephrine levels.These are controlled substances with potential side effects and a high abuse risk. Examples include methylphenidate ( Ritalin, Concerta), amphetamine and dextroamphetamine ( Adderall) or lisdexafetamine ( Vyvanse). Available in immediate-release (short-acting) and extended-release forms. These are the most commonly prescribed treatments and work by increasing dopamine and norepinephrine levels. Pharmacological treatments for ADHD include: Behavioral education should be considered as the first-line treatment for any case of ADHD, particularly in children aged less than 6 years of age, with mild symptoms, or if the family prefers this option over drug therapy.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |